Evaluation of near final height in boys with constitutional delay in growth and puberty

被引:10
作者
Rohani, Farzaneh [1 ,2 ]
Alai, Mohammad Reza [2 ]
Moradi, Sedighe [3 ]
Amirkashani, Davoud [4 ]
机构
[1] Iran Univ Med Sci, Pediat Growth & Dev Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Mofid Children Hosp, Dept Pediat Endocrinol & Metab Dis, Tehran, Iran
[3] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran
[4] Iran Univ Med Sci, Ali Asghar Childrens Hosp, Dept Pediat Endocrinol & Metab, Tehran, Iran
来源
ENDOCRINE CONNECTIONS | 2018年 / 7卷 / 03期
关键词
near final height; boys; constitutional delay; growth; puberty; STANDARDS;
D O I
10.1530/EC-18-0043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study was conducted to find out whether boys with constitutional delay in growth and puberty (CDGP) could attain their target height and predicted adult height (PAH) in adulthood or not. Methods: After measuring the height, weight, pubertal stage, parental height and bone age data of the patients at their first presentation were extracted from the files and their height and weight were measured at the end of the study, wrist X-Ray was performed in order to determine the bone age PAH was calculated using Bayley-Pinneau method and target height was estimated by mid parental height Final or near final heights of the patients were measured and compared with the target height and PAH. Results: The mean age at presentation and the end of study was 15.2 +/- 0.95, 20 +/- 0.75 years respectively. Mean of bone age at the beginning of study was 12 97 +/- 1 years and at the end of study were 17.6 +/- 0.58 years Mean of delayed bone age was 2.20 +/- 82 years Mean of the primary measured heights was 150.16 +/- 7cm (138-160cm). Mean of final or near final heights was 165.7 +/- 2.89cm (161-170.5cm). Final or near final heights in our subjects were smaller than either their PAH (16.7 +/- 2.89 vs 170.7 +/- 5.17) (P value <0.005) or target height (165.7 +/- 2.89 vs 171.8 +/- 4.65) (P value <0.0001). Conclusion: Most patients with CDGP do not reach their target height or predicted adult height; they are usually shorter than their parents and general population. Such patients need to be followed up until they reach their final height and, in some cases, adjunctive medical treatment might be indicated.
引用
收藏
页码:456 / 459
页数:4
相关论文
共 17 条
[1]   PREDICTIVE FACTORS IN THE DETERMINATION OF FINAL HEIGHT IN BOYS WITH CONSTITUTIONAL DELAY OF GROWTH AND PUBERTY [J].
ALBANESE, A ;
STANHOPE, R .
JOURNAL OF PEDIATRICS, 1995, 126 (04) :545-550
[2]  
Backeljauw PF., 2014, SPERLING MA PEDIAT E, V4th, P292, DOI DOI 10.1016/B978-1-4557-4858-7.00019-6
[3]   TABLES FOR PREDICTING ADULT HEIGHT FROM SKELETAL AGE - REVISED FOR USE WITH THE GREULICH-PYLE HAND STANDARDS [J].
BAYLEY, N ;
PINNEAU, SR .
JOURNAL OF PEDIATRICS, 1952, 40 (04) :423-441
[4]   Constitutional and Non-Constitutional Delay of Growth and Puberty [J].
Butenandt, Otfrid .
PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2017, 15 (02) :132-135
[5]   FINAL HEIGHT IN BOYS WITH UNTREATED CONSTITUTIONAL DELAY IN GROWTH AND PUBERTY [J].
CROWNE, EC ;
SHALET, SM ;
WALLACE, WHB ;
EMINSON, DM ;
PRICE, DA .
ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (10) :1109-1112
[6]   Boosting the Late-Blooming Boy: Use of Growth-Promoting Agents in the Athlete With Constitutional Delay of Growth and Puberty [J].
Curtis, Vanessa A. ;
Allen, David B. .
SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH, 2011, 3 (01) :32-40
[7]  
Greulich W. W., 1959, RADIOGRAPHIC ATLAS S, V2nd
[8]   Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty [J].
Hero, M ;
Wickman, S ;
Dunkel, L .
CLINICAL ENDOCRINOLOGY, 2006, 64 (05) :510-513
[9]   VARIATIONS IN PATTERN OF PUBERTAL CHANGES IN BOYS [J].
MARSHALL, WA ;
TANNER, JM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1970, 45 (239) :13-+
[10]  
Poyrazoglu F, 2005, J PEDIATR ENDOCR MET, V18, P171